Chinese medical and pharmaceutical-focused venture fund Bioventure Investment Management Ltd. and Tianjin-based medicine and healthcare investment fund Tasly Great Health Industry Fund have co-led a RMB100 million (US$14.5 million) series B round in Zhejiang POCTech Medical Corp., a company that specializes in the research and production of portable or wearable medical devices.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
